Clinical Trial Results:
A Phase 1/2, Ascending Multiple-Dose Study to Evaluate the Safety, Efficacy and
Pharmacokinetics of BMS-753493 in Subjects with Advanced Cancer.
Revised Protocol 04, incorporating Protocol Amendment 02 (v1.0, Date 16-Oct-2007), 03 (v1.0, Date 26-Nov-2007), 04 (v2.0, Date 20-May-2008), and 05 (v3.0, date 24-Mar-2009). And Pharmacogenetics Blood Sample Amendment 01 - Site specific (version 2.0, Date 16-Jul-2007).
Summary
|
|
EudraCT number |
2007-001433-34 |
Trial protocol |
GB |
Global completion date |
25 Mar 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
CA190-002_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.